Header Logo

Connection

Sarju Ganatra to Drug Administration Schedule

This is a "connection" page, showing publications Sarju Ganatra has written about Drug Administration Schedule.
Connection Strength

0.181
  1. Ganatra S, Sharma A, Levy MS. Re-Evaluating the Safety of Drug-Eluting?Stents in Cancer Patients. JACC Cardiovasc Interv. 2017 11 27; 10(22):2334-2337.
    View in: PubMed
    Score: 0.139
  2. Zhang L, Zlotoff DA, Awadalla M, Mahmood SS, Nohria A, Hassan MZO, Thuny F, Zubiri L, Chen CL, Sullivan RJ, Alvi RM, Rokicki A, Murphy SP, Jones-O'Connor M, Heinzerling LM, Barac A, Forrestal BJ, Yang EH, Gupta D, Kirchberger MC, Shah SP, Rizvi MA, Sahni G, Mandawat A, Mahmoudi M, Ganatra S, Ederhy S, Zatarain-Nicolas E, Groarke JD, Tocchetti CG, Lyon AR, Thavendiranathan P, Cohen JV, Reynolds KL, Fradley MG, Neilan TG. Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis. Circulation. 2020 06 16; 141(24):2031-2034.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.